APOC3 Interference for Familial Chylomicronaemia Syndrome

Patients with familial chylomicronaemia syndrome (FCS) have severe hypertriglyceridaemia due to genetically absent lipolytic capacity. They have a poor response to conventional therapies. To reduce the risk of potentially fatal pancreatitis, the management of FCS relies principally on a strict low-f...

Descripción completa

Detalles Bibliográficos
Autor principal: Hegele, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2022
Materias:
Cardiovascular Risk and Metabolic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835816/
https://www.ncbi.nlm.nih.gov/pubmed/36694895
http://dx.doi.org/10.17925/EE.2022.18.2.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835816/
https://www.ncbi.nlm.nih.gov/pubmed/36694895
http://dx.doi.org/10.17925/EE.2022.18.2.82

Ejemplares similares